Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
TEVA Stock | USD 16.51 0.01 0.06% |
About 55% of Teva Pharma's investor base is interested to short. The analysis of overall sentiment of trading Teva Pharma Industries stock suggests that many investors are impartial at this time. The current market sentiment, together with Teva Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharma Industries stock news signals to limit their universe of possible portfolio assets.
Teva |
Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, launching this month, will run for a minimum of three years PARSIPPANY, N.J., Dec. 11, 2024 -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , announced today the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to eligible patients in the United States free
Read at finance.yahoo.com
Teva Pharma Industries Current Investor Sentiment
Panic Vs Confidence
45
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Teva Pharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Teva Pharma Industries.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Teva Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Teva Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Teva Pharma Fundamental Analysis
We analyze Teva Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teva Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teva Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Teva Pharma is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Teva Pharma Industries Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
Peers
Teva Pharma Related Equities
SNDL | SNDL | 2.38 | ||||
LFCR | Lifecore Biomedical | 1.97 | ||||
TLRY | Tilray | 0.84 | ||||
HLN | Haleon Plc | 0.31 | ||||
CTLT | Catalent | 0.02 | ||||
ACB | Aurora Cannabis | 0.46 | ||||
VTRS | Viatris | 0.79 | ||||
TAK | Takeda Pharmaceutical | 1.04 | ||||
ZTS | Zoetis | 1.33 | ||||
CRON | Cronos | 1.53 | ||||
BHC | Bausch Health | 2.05 | ||||
CGC | Canopy Growth | 2.25 | ||||
SHPH | Shuttle Pharmaceuticals | 2.86 | ||||
ELAN | Elanco Animal | 3.89 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |